A comprehensive view of Eli Lilly & Co.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Eli Lilly and Company Submits European Patent Application for Peptides Comprising N-Formyl-Halogenated Methionine Residues and Engineered Antibody-Peptide Conjugates Thereof
Published: April 25, 2024 by Biotechnology Patent News
US Patent Issued to ELI LILLY and Co. on April 23 for "Compounds useful for inhibiting RET kinase" (Colorado, Montana Inventors)
Published: April 24, 2024 by U.S. Fed News
INTERNATIONAL PATENT: ELI LILLY AND COMPANY FILES APPLICATION FOR "SYNTHESIS OF 6-FLUORO-2-METHYLBENZO[D]THIAZOL-5-YL COMPOUNDS"
Published: April 23, 2024 by U.S. Fed News
INTERNATIONAL PATENT: ELI LILLY AND COMPANY FILES APPLICATION FOR "WEARABLE SENSOR FOR MONITORING SOLID AND LIQUID CONSUMPTION"
Published: April 23, 2024 by U.S. Fed News
INTERNATIONAL PATENT: ELI LILLY AND COMPANY FILES APPLICATION FOR "METHODS AND SYSTEMS FOR USING CAUSAL NETWORKS TO DEVELOP MODELS FOR EVALUATING BIOLOGICAL PROCESSES"
Published: April 23, 2024 by U.S. Fed News

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count